ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ataxia Telangiectasia

  • Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)
  • A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  • Open-Label Extension of EryDex Study IEDAT-04-2022
  • Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside
  • To Evaluate the Effects of EryDex in Patients With A-T
  • Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
  • MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia
  • NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  • N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
  • EDS in Ataxia Telangiectasia Patients
  • Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
  • Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
  • Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
  • Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
  • Baclofen Treatment of Ataxia Telangiectasia
  • Study for Treatment of Cancer in Children With Ataxia-telangiectasia
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group